Stephen Joseph Shuttleworth,Franck Alexandre Silva
申请号：
US15496511
公开号：
US10035785B2
申请日:
2017.04.25
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A compound of formula I: or a pharmaceutically acceptable salt thereof, wherein: R1, R2, R3, R and R6 are each independently (LQ)mY； R4 is H, halogen, optionally substituted aryl or optionally substituted alkyl； and； each X is independently CR7 or N. The compounds are PI3K inhibitors and therefore have potential utility in therapy.
